Comparison Overview

Sakura Finetek Europe

VS

Dentsply Sirona

Sakura Finetek Europe

Flemingweg 10a, Alphen aan den Rijn, The Netherlands, 2408 AV, NL
Last Update: 2025-03-04 (UTC)
Between 750 and 799

Empowering pathologists and lab technicians worldwide. When it comes to diagnosing cancer, there’s no time to wait. At Sakura we’re driven by our desire to advance cancer diagnosis through fully automated anatomic pathology. Our Mission: Advancing cancer diagnoses by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality and customer care.

NAICS: None
NAICS Definition: Others
Employees: 411
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Dentsply Sirona

13320 Ballantyne Corporate Pl, Charlotte, North Carolina, 28277, US
Last Update: 2025-03-04 (UTC)

A Global Total Solutions Provider Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, empowering dental professionals to provide better, safer and faster dental care. Our products and solutions include leading positions and platforms across consumables, equipment, technology, and specialty products. Dentsply Sirona is one global team that brings out the best in our people, lives and breathes high performance and personal accountability, acts with uncompromising integrity, improves the practice of dentistry with an unrelenting commitment to our customers and demonstrates a passion for innovation that shapes the dental industry. As The Dental Solutions Company™ Dentsply Sirona’s comprehensive solutions offering includes leading product brands across consumables, equipment, technology and specialty products. With the broadest clinical education platform and an unparalleled commitment to R&D in dentistry, our mission and vision guide us to continuously aim higher, support our customers and advance patient care around the world. Dentsply Sirona’s Global Headquarters is located in Charlotte, North Carolina. Our shares are listed in the United States on NASDAQ under the symbol XRAY. We care about your privacy - you can view our Privacy Policy here: http://www.dentsplysirona.com/privacy.

NAICS: None
NAICS Definition: Others
Employees: 10,799
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/sakura-finetek.jpeg
Sakura Finetek Europe
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/dentsplysirona.jpeg
Dentsply Sirona
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Sakura Finetek Europe
100%
Compliance Rate
0/4 Standards Verified
Dentsply Sirona
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Device Industry Average (This Year)

No incidents recorded for Sakura Finetek Europe in 2025.

Incidents vs Medical Device Industry Average (This Year)

No incidents recorded for Dentsply Sirona in 2025.

Incident History — Sakura Finetek Europe (X = Date, Y = Severity)

Sakura Finetek Europe cyber incidents detection timeline including parent company and subsidiaries

Incident History — Dentsply Sirona (X = Date, Y = Severity)

Dentsply Sirona cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/sakura-finetek.jpeg
Sakura Finetek Europe
Incidents

No Incident

https://images.rankiteo.com/companyimages/dentsplysirona.jpeg
Dentsply Sirona
Incidents

No Incident

FAQ

Dentsply Sirona company demonstrates a stronger AI Cybersecurity Score compared to Sakura Finetek Europe company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Dentsply Sirona company has disclosed a higher number of cyber incidents compared to Sakura Finetek Europe company.

In the current year, Dentsply Sirona company and Sakura Finetek Europe company have not reported any cyber incidents.

Neither Dentsply Sirona company nor Sakura Finetek Europe company has reported experiencing a ransomware attack publicly.

Neither Dentsply Sirona company nor Sakura Finetek Europe company has reported experiencing a data breach publicly.

Neither Dentsply Sirona company nor Sakura Finetek Europe company has reported experiencing targeted cyberattacks publicly.

Neither Sakura Finetek Europe company nor Dentsply Sirona company has reported experiencing or disclosing vulnerabilities publicly.

Neither Sakura Finetek Europe nor Dentsply Sirona holds any compliance certifications.

Neither company holds any compliance certifications.

Dentsply Sirona company has more subsidiaries worldwide compared to Sakura Finetek Europe company.

Dentsply Sirona company employs more people globally than Sakura Finetek Europe company, reflecting its scale as a Medical Device.

Neither Sakura Finetek Europe nor Dentsply Sirona holds SOC 2 Type 1 certification.

Neither Sakura Finetek Europe nor Dentsply Sirona holds SOC 2 Type 2 certification.

Neither Sakura Finetek Europe nor Dentsply Sirona holds ISO 27001 certification.

Neither Sakura Finetek Europe nor Dentsply Sirona holds PCI DSS certification.

Neither Sakura Finetek Europe nor Dentsply Sirona holds HIPAA certification.

Neither Sakura Finetek Europe nor Dentsply Sirona holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

The Bold Page Builder plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the ‘percentage’ parameter in all versions up to, and including, 5.4.5 due to insufficient input sanitization and output escaping. This makes it possible for authenticated attackers, with Contributor-level access and above, to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page.

Risk Information
cvss3
Base: 6.4
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N
Description

The ComboServlet in Liferay Portal 7.4.0 through 7.4.3.111, and older unsupported versions, and Liferay DXP 2023.Q4.0 through 2023.Q4.2, 2023.Q3.1 through 2023.Q3.5, 7.4 GA through update 92, 7.3 GA through update 35, and older unsupported versions does not limit the number or size of the files it will combine, which allows remote attackers to create very large responses that lead to a denial of service attack via the URL query string.

Risk Information
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and create arbitrary directories on the target machine.

Risk Information
cvss3
Base: 4.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:N
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A relative path traversal vulnerability was discovered in Productivity Suite software version 4.4.1.19. The vulnerability allows an unauthenticated remote attacker to interact with the ProductivityService PLC simulator and delete arbitrary files on the target machine.

Risk Information
cvss3
Base: 7.5
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:L/A:H
cvss4
Base: 8.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:H/SC:N/SI:L/SA:L/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X